Ridgeback Biotherapeutics LP

As more and more therapies from small- to mid-size biopharma ventures enter Western markets, Japan is taking renewed steps to attract such products to its borders by enriching funding programs to supp

Regeneron Pharmaceuticals, Inc. is aiming to develop a monoclonal antibody for preventing COVID-19 in vulnerable populations that it hopes will be able to overcome the mechanisms of resistance that i

The European Medicines Agency has recommended that two new drugs be approved for marketing in the EU – AbbVie ’s Aquipta (atogepant monohydrate), for the prophylaxis of migraine, and GSK ’s Jesduvro

The European Medicines Agency could this week decide whether to reverse the opinion it adopted in February recommending against pan-EU marketing approval for MSD / Ridgeback Biotherapeutics ’ COVID-1